Cyto-Barr has expertise, experience and owns patents and materials for applications in diagnostic testing, specifically in association with Epstein-Barr virus (EBV) or Cytomegalovirus (CMV).

Cyto-Barr is looking for partnerships.

In these partnerships we focus on a supportive role, where we assist in expertise, technology and supply of essential materials. Moreover, a license on our patents will allow our partners to enter market segments in a reliable way.

Nowadays, Cyto-Barr has more than 40 industrial partners worldwide in diagnostics and therapies for EBV and CMV. On top of this, it has several NGO partners as well. Furthermore, Cyto-Barr markers are leading worldwide in the field of EBV routine diagnostics. Cyto-Barr reagents are chemically defined which minimizes production risks and shortens time to market.